approval · primary record
ARIPIPRAZOLE
FDA · NDA · 2025-03-20
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-03-20 |
| Brand | OPIPZA |
| Sponsor | XIAMEN LP PHARM CO |
| Route | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:34:39.229Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:ARIPIPRAZOLE:2025-03-20
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.